Alaunos Therapeutics, Inc. TCRT

Full chart Compare
Set alert

Price alert · TCRT

All alert types
1.86 USD +0.11 (+6.29%)

At closeNov 3, 2026, 4:00 PM EST

1.80 -0.06 -3.23%

After hours · Nov 3, 4:00 PM ET

1.70 Day range 1.90
0.72 52-week range 4.50
YTD
-42.41%
1 year
-31.37%

Revenue & Expenses

Other Income → Expenses: $49.00KExpenses → Gross Loss: $1.36MExpenses → Selling, General & Admin: $2.87MExpenses → Research & Development: $1.36MOther Operating Income → Expenses: $1.36MNet Loss → Expenses: $4.18MRevenue → Cost of Revenue: $5.00KOther Income$49.00KOther Operating Income$1.36MNet Loss$4.18MCost of Revenue$1.36MExpenses$5.59MGross Loss$1.36MSelling, General & Admin$2.87MResearch & Development$1.36MRevenue$5.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

TCRT annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
5.00K10.00K5.00K2.92M398.00K
5.00K10.00K5.00K2.92M398.00K
-4.22M-4.81M-34.56M-35.10M-77.55M
-4.18M-4.68M-35.14M-37.73M-78.75M
-2.20-2.92-21.97-26.10-55.00
TCRT annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.39M1.09M6.06M53.04M76.10M
2.97M2.75M8.26M64.94M94.86M
813.00K692.00K1.96M26.38M36.81M
2.15M2.06M6.31M38.55M58.06M
TCRT annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-2.87M-4.97M-30.14M-29.23M-61.47M
-98.00K01.35M-193.00K-3.32M
3.26M0-18.14M6.37M25.78M
-98.00K01.35M-193.00K-3.32M
294.00K-4.97M-46.93M-23.06M-39.02M